$22.44
▼ -1.4% Today
as of Sep 4, 16:53 ET
Last 30 days
Recent Press Releases & News
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors?
PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026
PROCEPT BioRobotics (PRCT) Q2 2026 Earnings Call Transcript
Overview
52-week range
$17
$42
23% of range
Avg surprise (last 2)
+11.4%
Avg reaction (last 1)
-5.6%
0% positive
Latest IV / EM
55%
EM ±8.5% · $23 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.47 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-0.56 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.38 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $-0.35 | $-0.41 | +14.6% | — | — | earnings |
| Thu Apr 24, 2025 | Mar/2025 | $-0.45 | $-0.49 | +8.2% | — | -5.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.40 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.50 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.51 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.51 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.56 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.63 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $94M | $83M | — | $83M | $79M | $69M | — | $58M |
| Cost of revenue | $32M | $29M | — | $29M | $27M | $25M | — | $21M |
| Gross profit | $62M | $54M | — | $54M | $52M | $44M | — | $37M |
| Operating income | $-27M | $-33M | — | $-23M | $-22M | $-27M | — | $-22M |
| Net income | $-27M | $-32M | — | $-21M | $-20M | $-25M | — | $-21M |
| EPS (diluted) | $-0.47 | $-0.56 | — | $-0.38 | $-0.35 | $-0.45 | — | $-0.40 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $228M | $246M | $287M | $294M | $303M | $316M | $334M | $197M |
| Inventory | $77M | $78M | $71M | $67M | $67M | $62M | $56M | $51M |
| Total current assets | $420M | $428M | $450M | $455M | $458M | $466M | $482M | $323M |
| Total assets | $479M | $487M | $508M | $512M | $513M | $519M | $534M | $374M |
| Long-term debt | $52M | $52M | $52M | $52M | $52M | $51M | $51M | $51M |
| Total liabilities | $139M | $139M | $142M | $131M | $127M | $130M | $132M | $133M |
| Total equity | $340M | $348M | $366M | $380M | $386M | $389M | $402M | $241M |